Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (3187)	3/25/2001 1:16:11 PM
From: scaram(o)uche	Respond to of 52153

For those at and on CNBC that continue to talk about (1) the "outperformance" of biotech, not realizing that ^BTK bears little resemblance to what's happening with 95% of the sector's stocks, and (2) an absence of capitulation, here are some Thursday morning charts (in context)........... quote.yahoo.com quote.yahoo.com quote.yahoo.com quote.yahoo.com quote.yahoo.com etc. etc. etc. That fund manager that was selling NOVN at $17? Was he/she the same manager that was sticking clients with capital gains -- but no profit -- last year? Overzealous fund managers, absorbing any supply, February 2000. Why do they still have jobs?